Sector: Health Care
Director information for HAEMONETICS CORP (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Charles J. Dockendorff | [] | ["Audit Committee","Governance and Compliance Committee"] | 2026 | ||
| Christopher A. Simon | President and Chief Executive Officer, Haemonetics | 62 | ["President and Chief Executive Officer of Haemonetics Corporation","Senior Partner of McKinsey & Company","Commercial roles with Baxter Healthcare Corporation","U.S. Army Infantry Officer"] | [] | 2026 |
| Claire Pomeroy | Chair | [] | ["Technology Committee"] | 2026 | |
| CLAIRE POMEROY, M.D. | President, Albert and Mary Lasker Foundation | 71 | ["Expert in infectious diseases","Broad leadership experience in health system administration, healthcare delivery, medical research and public health","Former Dean of the UC Davis School of Medicine and Vice Chancellor of the UC Davis Health System","Chair of the Center for Women in Academic Medicine and Science","Director of multiple health-related foundations and organizations"] | ["Compensation Committee","Technology Committee","Compensation","Technology"] | 2026 |
| Diane M. Bryant | Former Chairman and Chief Executive Officer, NovaSignal Corp. | 64 | ["Chairman and Chief Executive Officer of NovaSignal Corp.","Chief Operating Officer of Google Cloud","32 years at Intel Corporation in leadership positions","Expertise in technology and innovation, cybersecurity, and business development"] | ["Compensation","Technology","Compensation Committee","Technology Committee"] | 2026 |
| ELLEN M. ZANE | CEO Emeritus of Tufts Medical Center; Chair | 74 | ["Former President and Chief Executive Officer of Tufts Medical Center","Former Network President for Partners Healthcare System","Former Chief Executive Officer of Quincy Hospital","Experienced in strategy development, finance, operational effectiveness and enterprise risk management","Recognized by NACD Directorship 100 for 2025","Recipient of the Lifetime Achievement Award in Governance from NACD of New England"] | ["Governance and Compliance Committee","Governance and Compliance"] | 2026 |
| LLOYD E. JOHNSON | Retired Global Managing Director, Finance and Internal Audit, Accenture Corporation; Chair | 72 | ["Retired Global Managing Director, Finance and Internal Audit, Accenture Corporation","Former Executive Director, M&A and General Auditor for Delphi Automotive PLC","Senior financial leadership positions at Emerson Electric Corporation, Sara Lee Corporation and Shaw Food Services","Board Chair at AARP and Board of Trustee of the University of South Carolina Business Partnership Foundation","Certified public accountant","Holds the National Association of Corporate Directors' Directorship Certification"] | ["Audit Committee","Governance and Compliance Committee","Audit","Governance and Compliance"] | 2026 |
| Mark W. Kroll | [] | ["Technology Committee"] | 2026 | ||
| MARK W. KROLL, Ph.D. | Retired Senior Executive Officer, St. Jude Medical, Inc. | 73 | ["Adjunct Full Professor of Biomedical Engineering at the University of Minnesota","Former Senior Vice President and Chief Technology Officer at St. Jude Medical, Inc.","Expertise in cardiovascular devices and instrumentation","More than 25 years of experience","Named inventor of more than 380 U.S. patents","Fellow of several prestigious medical and engineering societies","Recipient of the Engineering in Medicine and Biology Society’s Career Achievement Award"] | ["Compensation Committee","Technology Committee","Compensation","Technology"] | 2026 |
| MICHAEL J. COYLE | Director; Former President and Chief Executive Officer, iRhythm Technologies, Inc. | 64 | ["Former President and Chief Executive Officer, iRhythm Technologies, Inc.","Executive Vice President and Group President, Cardiac and Vascular Group of Medtronic plc","Former President of the Cardiac Rhythm Management division at St. Jude Medical Inc.","Leadership positions at St. Jude and Eli Lilly & Company","Holds six U.S. patents related to cardiovascular medical device products and technologies"] | ["Audit Committee","Technology Committee","Audit","Technology"] | 2026 |
| Robert E. Abernathy | Retired Chairman and Chief Executive Officer, Halyard Health, Inc. | 71 | ["Chairman of the Board of Directors and Chief Executive Officer of Halyard Health Inc.","Leadership experience in the healthcare industry","Enterprise risk management expertise"] | ["Compensation","Governance and Compliance","Compensation Committee","Governance and Compliance Committee"] | 2026 |
